Spherics Inc

Steraloids, located in Newport, RI, is a leading provider of steroid research standards and starting materials, boasting an extensive catalogue of over 2,700 products, including estrogens, bile acids, and hormones. With more than 60 years of experience, the company serves a diverse clientele, including research institutions, pharmaceutical companies, and law enforcement agencies, while offering custom syntheses to meet specific research needs. Renowned for its high-quality standards, Steraloids is licensed by the DEA in the U.S.A. and specializes in the synthesis of both synthetic and endogenous steroids for research testing and synthesis. Their commitment to individualized service ensures that all orders, from bulk quantities to custom requests, are tailored to the unique requirements of their clients. Generated from the website

Opexa Therapeutics is a biotechnology company that specializes in the development of patient-specific cellular therapies for the treatment of autoimmune diseases, such as multiple sclerosis and diabetes. It offers Tovaxin, which is a vaccine for early relapsing multiple sclerosis. The company also offers an adult stem cell program that enables the production of multipotent cells generated from patients white blood cells and provides means to differentiate these stem cells into other tissue types. Opexa Therapeutics offers solutions that minimize the threat of treatment rejection. It operates clinical advisory boards for multiple sclerosis and diabetes that take care of the supervision of related procedures. The company provides products to target individual s disease progression and modification.

Ironwood Pharmaceuticals, based in Boston, MA, is a prominent healthcare company dedicated to advancing the treatment of gastrointestinal (GI) diseases and enhancing the standard of care for GI patients. With a focus on innovation, Ironwood aims to address the needs of the millions of Americans affected by GI disorders, thereby reducing hospital visits and healthcare costs associated with these conditions. Through their deep understanding of the unique GI patient journey, Ironwood Pharmaceuticals is committed to delivering meaningful solutions that improve patient outcomes and quality of life. The company's culture emphasizes collaboration and innovation, ensuring that their team members work together to make a significant difference in the lives of those suffering from gastrointestinal diseases. Generated from the website